Advancement in Injection Devices ~Relationships between Transitions in Injection Pen Devices of Diabetes Treatment and Diabetic Patient Education~

Abstract

A basal-bolus regimen that better matches physiological insulin secretion is offered as a basis of insulin regimen to achieve tight control of blood glucose in a daily life. An insulin regimen includes Multiple Daily Injections (MDI) using insulin pens and Continuous Subcutaneous Insulin Infusion (CSII) using insulin pumps. Administrating insulin subcutaneously with a dose accuracy requires high-precision and high-quality delivery devices, as well as usability, easier to understand, comfort, and reliability for patients. The development of insulin delivery devices has added an improvement in these items through the long periods of time and stages. In the future it is expected to develop delivery devices that are able to deal with an “individual” including an addition of assistive functions for ensuring more accuracy in patients’ procedures; a more improved portability than before; and having programming functions to support detailed parts of each patients’ life under diabetic care.